HUT50782A - Process for producing bicyclic amines - Google Patents

Process for producing bicyclic amines

Info

Publication number
HUT50782A
HUT50782A HU891646A HU164689A HUT50782A HU T50782 A HUT50782 A HU T50782A HU 891646 A HU891646 A HU 891646A HU 164689 A HU164689 A HU 164689A HU T50782 A HUT50782 A HU T50782A
Authority
HU
Hungary
Prior art keywords
treatment
same
neuronal death
bicyclic amines
delayed neuronal
Prior art date
Application number
HU891646A
Other languages
English (en)
Other versions
HU206681B (en
Inventor
Hisashi Takasugi
Atsushi Kuno
Mitsuru Ohkubo
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of HUT50782A publication Critical patent/HUT50782A/hu
Publication of HU206681B publication Critical patent/HU206681B/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Materials For Medical Uses (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU891646A 1988-04-05 1989-04-05 Process for producing doublecyclic amines and pharmaceutical compositions containing them HU206681B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888807922A GB8807922D0 (en) 1988-04-05 1988-04-05 Isoquinoline compound & process for preparation thereof

Publications (2)

Publication Number Publication Date
HUT50782A true HUT50782A (en) 1990-03-28
HU206681B HU206681B (en) 1992-12-28

Family

ID=10634575

Family Applications (1)

Application Number Title Priority Date Filing Date
HU891646A HU206681B (en) 1988-04-05 1989-04-05 Process for producing doublecyclic amines and pharmaceutical compositions containing them

Country Status (16)

Country Link
US (1) US5059608A (hu)
EP (1) EP0336228B1 (hu)
JP (1) JP2674199B2 (hu)
KR (1) KR890016013A (hu)
CN (1) CN1036758A (hu)
AT (1) ATE113937T1 (hu)
AU (1) AU624128B2 (hu)
DE (1) DE68919252T2 (hu)
DK (1) DK161889A (hu)
FI (1) FI891582A (hu)
GB (1) GB8807922D0 (hu)
HU (1) HU206681B (hu)
IL (1) IL89736A0 (hu)
NO (1) NO891390L (hu)
PH (1) PH26281A (hu)
ZA (1) ZA892230B (hu)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH27337A (en) * 1987-03-27 1993-06-08 Schering Corp Substituted benzazepines their preparation and pharmaceutical compositions containing them
US4902695A (en) * 1989-02-13 1990-02-20 Eli Lilly And Company Excitatory amino acid receptor antagonists
US5837808A (en) * 1991-08-20 1998-11-17 Baxter International Inc. Analogs of hirudin
US5246943A (en) * 1992-05-19 1993-09-21 Warner-Lambert Company Substituted 1,2,3,4-tetahydroisoquinolines with angiotensin II receptor antagonist properties
US5236934A (en) * 1992-08-26 1993-08-17 E. I. Du Pont De Nemours And Company 1,2,3,4-tetrahydroisoquinolines useful in the treatment of CNS disorders
US5360568A (en) * 1993-11-12 1994-11-01 Lever Brothers Company, Division Of Conopco, Inc. Imine quaternary salts as bleach catalysts
BR9408038A (pt) * 1993-11-12 1996-12-24 Unilever Nv Composição de branqueamento e processo para branquear um substrato manchado
US5360569A (en) * 1993-11-12 1994-11-01 Lever Brothers Company, Division Of Conopco, Inc. Activation of bleach precursors with catalytic imine quaternary salts
DZ2446A1 (fr) * 1997-03-18 2003-01-11 Smithkline Beecham Plc Nouveaux composés
JP2001518468A (ja) * 1997-09-30 2001-10-16 モレキュラー デザインズ インターナショナル,インコーポレイテッド β3アドレナリン受容体拮抗薬、拮抗薬合成物およびこれらの応用方法
US6593341B2 (en) 2001-03-29 2003-07-15 Molecular Design International, Inc. β3-adrenoreceptor agonists, agonist compositions and methods of making and using the same
US6596734B1 (en) 2002-10-11 2003-07-22 Molecular Design International, Inc. Tetrahydroisoquinoline compounds for use as β3-adrenoreceptor agonists
KR100812843B1 (ko) * 2005-06-01 2008-03-11 한화석유화학 주식회사 3,4-디히드로이소퀴놀리늄 염 유도체

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR204327A1 (es) * 1973-07-20 1975-12-22 Fujisawa Pharmaceutical Co Procedimiento para la preparacion de derivados de 1,2,3,4-tetrahidroisoquinolina
US3963725A (en) * 1973-07-20 1976-06-15 Fujisawa Pharmaceutical Co., Ltd. 1,2,3,4-Tetrahydroisoquinoline derivatives and the preparation thereof
JPS5734275B2 (hu) * 1973-07-30 1982-07-22
US4755218A (en) * 1985-12-31 1988-07-05 Monsanto Company Haloacyl 1-substituted-1,2,3,4-tetrahydro-isoquinolines as herbicide antidotes
GB8800397D0 (en) * 1988-01-08 1988-02-10 Sandoz Ltd Improvements in/relating to organic compounds

Also Published As

Publication number Publication date
EP0336228A1 (en) 1989-10-11
HU206681B (en) 1992-12-28
AU624128B2 (en) 1992-06-04
NO891390L (no) 1989-10-06
JPH01294664A (ja) 1989-11-28
CN1036758A (zh) 1989-11-01
FI891582A (fi) 1989-10-06
NO891390D0 (no) 1989-04-03
GB8807922D0 (en) 1988-05-05
DE68919252D1 (de) 1994-12-15
KR890016013A (ko) 1989-11-27
IL89736A0 (en) 1989-09-28
DE68919252T2 (de) 1995-03-23
AU3243289A (en) 1989-10-12
DK161889D0 (da) 1989-04-04
DK161889A (da) 1989-10-06
US5059608A (en) 1991-10-22
JP2674199B2 (ja) 1997-11-12
ATE113937T1 (de) 1994-11-15
EP0336228B1 (en) 1994-11-09
FI891582A0 (fi) 1989-04-03
PH26281A (en) 1992-04-10
ZA892230B (en) 1989-11-29

Similar Documents

Publication Publication Date Title
HUT50782A (en) Process for producing bicyclic amines
RU94013439A (ru) Гетероциклические соединения, способ их получения, фармацевтическая композиция и способ лечения
BG86132A (bg) Производни на пиридазинамин
UA40589C2 (uk) Спосіб лікування людини, що страждає від вірусної інфекції, фармацевтична композиція, комбінація речовин для отримання ліків та фармацевтична комбінація
PH25508A (en) Substituted quinazoline derivatives for use in gastrointestinal diseases
EP0495982A4 (en) Bicyclic pyrimidine derivative, method of producing the same, and pharmaceutical preparation containing the same as active ingredient
IL93325A0 (en) Isoquinoline derivatives,process for their preparation and pharmaceutical compositions containing them
ES2052717T3 (es) Uso de derivados de indolona para la preparacion de medicamentos para el tratamiento de la enfermedad de parkinson.
ATE218061T1 (de) Verfahren zur verbesserung der wahrnehmung mit partiellen agonisten des glycin/nmda- rezeptorkomplexes
HK1004985A1 (en) N-(3-piperidinylcarbonyl)-beta-alanine derivatives as paf antagonists
DE68926115D1 (de) Verfahren zur behandlung von akne
NO864443D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive n-substituerte 3-piperidin- eller 3-pyridin-karboksylsyrederivater.
GB9109972D0 (en) Therapeutic compounds
DK0624569T3 (da) MMDA-antagonister
MY104521A (en) Treatment of depression.
MX9405209A (es) Uso de las n-(piridinil)-1h-indol-1-aminas en la preparacion de unmedicamento para el tratamiento de desordenes obsesivo-compulsivos.
IL89351A0 (en) 4,5,6,7-tetrahydroisothiazolo(4,5-c)pyridines,process for their preparation and pharmaceutical compositions containing them
IL83586A (en) Acylated aminoalkyl and hydroxyalkyl substituted spirocondensed hexahydroarylquinolizines and peripheral alpha2 adrenoceptor antagonist pharmaceutical compositions containing them
NO873571L (no) Fremgangsmaate for fremstilling av et terapeutisk virksomtpreparat.
GB1420976A (en) Pharmaceutical compositions for use in the treatment of certain respiratory diseases or conditions in prematurely born children
RU93016575A (ru) Антигипоксическое средство
PT85429A (en) Process for the preparation of pharmaceutical compositions
TH9090A (th) ส่วนผสมเภสัชกรรมชนิดใหม่ และผลิตภัณฑ์เภสัชกรรมใหม่ ที่ทำให้ที่ทำให้เกิดการสร้างลิวโคไซท์ขึ้นใหม่ และการใช้ในการบำบัดโรคจากผู้ที่มีอาการของภูมิคุ้มกันไม่เพียงพอ
TH7755A (th) ฟลูออซิทีน แอนาลอก
JPS6442436A (en) Rheumatoid arthritis therapeutical composition

Legal Events

Date Code Title Description
HMM4 Cancellation of final prot. due to non-payment of fee